Regulatory Webcast RECORDING: Biomarker Strategies and Implementation in Drug Development

(Recorded live on Tuesday, July 14, 2020)

Biomarkers are important tools for successful biopharmaceutical-targeted drug development and regulatory approval. Biomarkers can be diagnostic and/or prognostic, indicative of precision drug targeting. As such, biomarkers are increasingly used to characterize disease and monitor treatment performance, enrich responsive patient enrollment in clinical trials, and support regulatory approval process and labeling.

Biomarker assay development should start early in the drug development cycle, and its timing needs to be carefully crafted upon individual development phases. This co-development process can be a particular challenge for emerging biotech companies with limited funds and resources and requires decisions to be made on how to optimize and advance biomarker assay development to support preclinical or clinical development. Other considerations include the challenging decision point of when to transition the assay into companion diagnostic development, which comes with additional regulatory requirements.

With Suzana Corritori, MD, Ph.D., MSc and Flagship COO, Meredith James, for this webinar to learn practical considerations and guidance for emerging biotech companies to navigate through successful biomarker strategy implementation into multi-faceted drug development and regulatory approval.

Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.

Recent Posts

Spatial Biology for Drug Development Summit

Visit Flagship at the Spatial Biology for Drug Development Summit. October 11-13, 2023. Join us at the inaugural Spatial Biology for Drug Development Summit to explore implementation strategies, challenges in interpretation, and how this rapidly changing technology is...

13th Annual World Clinical Biomarkers & CDx Summit

Visit us at booth E30 to learn how we can partner for end-to-end support of your research and development program. We help you analyze more data in more depth, so you can produce more effective therapies. Attending the 13th World Clinical Biomarkers & CDx Summit?...

June 2023 Annual Meeting

Flagship Bioscience is your source for spatial biology expertise, moving your research forward every step of the way. Our mission is to explore complex biomarkers within the context of disease in order to advance your precision medicine strategy. Attending the 2023...

American Society of Gene and Cell Therapy Annual Meeting

Visit us at booth 821 at the ASGCT Annual Meeting.  We help you analyze more data in more depth, so you can produce more effective therapies. Attending the ASGCT Annual Meeting? Schedule a meeting with our team to discuss our: AI-powered digital pathology solutions...

American Association for Cancer Research Annual Meeting

Visit Us at Booth 2866 in the West Building, Level 2 Flagship Biosciences is your source for spatial biology expertise, moving your research forward every step of the way. Our mission is to explore complex biomarkers within the context of disease in order to advance...